StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Constellation Cloud Software Platform Revenue [legacy by Year

Constellation Cloud Software Platform Revenue ($M) [legacy through Q3 2019] ($M)

Natera Constellation Cloud Software Platform Revenue [legacy: $4.84M in FY2018, up 14.4% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2018
4.84
Period ended Dec 31, 2018
Change on a year earlier
+14.4%
4.23 in FY2017
History
3 years
Since FY2016
Sources
1
Form 10-K (2019-03-15)

Where the FY2018 figure comes from

Source: Form 10-K (2019-03-15) ↗

Reported in Form 10-K/10-Q Note — Disaggregated Licensing Revenue (2016–2019Q3).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConstellation Cloud Software Platform Revenue ($M) [legacy through Q3 2019] ($M)Year on yearSource
FY2018Dec 31, 20184.84+14.4%Form 10-K (2019-03-15) ↗
FY2017Dec 31, 20174.23+36.0%Form 10-K (2019-03-15) ↗
FY2016Dec 31, 20163.11–Form 10-K (2019-03-15) ↗

Cite this data

StockData. (2026). Natera Constellation Cloud Software Platform Revenue [legacy ($M), annual FY2016–FY2018 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-legacy-constellation

See every metric in the Natera KPI table. Data updated Nov 2, 2026.